FPF

FNY Partners Fund Portfolio holdings

AUM $183M
1-Year Est. Return 31.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+31.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$600M
AUM Growth
+$33.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
735
New
Increased
Reduced
Closed

Top Buys

1 +$57.1M
2 +$16.3M
3 +$15.7M
4
NVS icon
Novartis
NVS
+$11.9M
5
ASML icon
ASML
ASML
+$10.9M

Top Sells

1 +$68.2M
2 +$25M
3 +$16.7M
4
PRXL
Parexel International Corp
PRXL
+$10.2M
5
HUN icon
Huntsman Corp
HUN
+$9.82M

Sector Composition

1 Healthcare 19.07%
2 Technology 15.62%
3 Consumer Discretionary 14.54%
4 Financials 10.38%
5 Consumer Staples 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDMN
526
DELISTED
Kadmon Holdings, Inc.
KDMN
-2,000
MSGN
527
DELISTED
MSG Networks Inc.
MSGN
-1,500
AT
528
DELISTED
Atlantic Power Corporation
AT
-30,128
GWPH
529
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-5,200
RILYZ
530
DELISTED
B. Riley Financial, Inc. 7.50% Senior Notes Due 2027
RILYZ
-700
SINA
531
DELISTED
Sina Corp
SINA
-700
DX.PRB
532
DELISTED
Dynex Capital, Inc. 7.625% Series B Cumulative Redeemable Preferred Stock
DX.PRB
-3,000
FIT
533
DELISTED
Fitbit, Inc. Class A common stock
FIT
-100
DNKN
534
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-3,900
IOTS
535
DELISTED
Adesto Technologies Corp
IOTS
-3,400
AAL icon
536
American Airlines Group
AAL
$8.87B
-2,000
AAPL icon
537
Apple
AAPL
$3.77T
0
ABBV icon
538
AbbVie
ABBV
$386B
-2,800
ACAD icon
539
Acadia Pharmaceuticals
ACAD
$4.33B
0
ADBE icon
540
Adobe
ADBE
$123B
-380
ADSK icon
541
Autodesk
ADSK
$56.9B
0
AKAM icon
542
Akamai
AKAM
$14.7B
-100
ALB icon
543
Albemarle
ALB
$21.7B
0
ALGN icon
544
Align Technology
ALGN
$11.8B
0
ALTO icon
545
Alto Ingredients
ALTO
$202M
0
AMAT icon
546
Applied Materials
AMAT
$267B
-19,900
AMC icon
547
AMC Entertainment Holdings
AMC
$734M
0
AMD icon
548
Advanced Micro Devices
AMD
$411B
-5,000
ANAB icon
549
AnaptysBio
ANAB
$1.31B
-500
APO icon
550
Apollo Global Management
APO
$77.1B
-19,500